1. Home
  2. BWXT vs ROIV Comparison

BWXT vs ROIV Comparison

Compare BWXT & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BWX Technologies Inc.

BWXT

BWX Technologies Inc.

N/A

Current Price

$197.72

Market Cap

17.9B

Sector

N/A

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$28.66

Market Cap

20.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWXT
ROIV
Founded
1867
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.9B
20.7B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
BWXT
ROIV
Price
$197.72
$28.66
Analyst Decision
Buy
Strong Buy
Analyst Count
9
8
Target Price
$204.60
$27.56
AVG Volume (30 Days)
739.3K
4.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.55%
N/A
EPS Growth
16.61
N/A
EPS
3.58
N/A
Revenue
$1,687,738,000.00
$29,053,000.00
Revenue This Year
$18.90
N/A
Revenue Next Year
$10.10
$385.85
P/E Ratio
$54.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.21
$8.73
52 Week High
$220.57
$30.33

Technical Indicators

Market Signals
Indicator
BWXT
ROIV
Relative Strength Index (RSI) 46.87 57.28
Support Level $187.01 $26.94
Resistance Level $218.46 N/A
Average True Range (ATR) 9.00 0.97
MACD -1.28 -0.10
Stochastic Oscillator 28.25 49.23

Price Performance

Historical Comparison
BWXT
ROIV

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: